It is worth noting that recently Kosacka and colleagues found that OSA patients with increased UA concentration have a higher risk of atherosclerosis, as indicated by a higher level of soluble proatherogenic ligand CD40, and a higher prevalence of cardiovascular adverse events [56]. This evidence concerns the gene CD40 and atherosclerosis.